ROBERTA HAHN: Open Payments
NPI 1770936866 · SAINT LOUIS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,692 in 84 payments from 22 companies in 2025. Trend: 2023 $1,188 · 2024 $2,274 · 2025 $1,692
Food & beverage: $1,692
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $577 |
| AstraZeneca Pharmaceuticals LP | 3 | $187 |
| Amgen Inc. | 13 | $171 |
| Neurocrine BioSciences, Inc. | 5 | $103 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Novo Nordisk Inc | 3 | $77 |
| PFIZER INC. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Astellas Pharma US Inc | 2 | $51 |
| Paratek Pharmaceuticals, Inc. | 2 | $43 |
Products named: CAPLYTA, FARXIGA, OTEZLA, INGREZZA, Auvelity, REXULTI, Veozah, EVENITY.
Industry payments across MI — which companies pay providers there.
